---
title: "Grand Fortune Capital (HK) Discloses Investment at Baird Medical with 19.1% Stake"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294556410.md"
description: "Grand Fortune Capital (HK) disclosed a 19.1% beneficial stake in Baird Medical Investment Holdings Ltd via a Schedule 13D filed on July 31, 2026. Following the business combination with ExcelFin Acquisition Corp., Grand Fortune plans to remain involved and may engage with management regarding strategy, governance, and potential transactions. The Hong Kong-based investment holding company retains flexibility to adjust its position."
datetime: "2026-07-31T21:06:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294556410.md)
  - [en](https://longbridge.com/en/news/294556410.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294556410.md)
generator: "portal-rs"
---

# Grand Fortune Capital (HK) Discloses Investment at Baird Medical with 19.1% Stake

Grand Fortune Capital (HK) Company Limited reported a 19.1% beneficial stake in Baird Medical Investment Holdings Ltd. The Schedule 13D was filed on Jul. 31, 2026, following the company’s business combination with ExcelFin Acquisition Corp. The position suggests Grand Fortune Capital (HK) could engage with management on strategy and future deals.

**Investor Intent**

Grand Fortune Capital (HK) holds the shares for investment but plans to stay involved. It "may engage in discussions with the Issuer's management and board of directors regarding the Issuer's business, operations, capitalization, corporate governance, \[and\] strategic transactions," including financings, asset sales, mergers, or other combinations.

The group keeps flexibility to change its position. It "may from time to time acquire additional securities of the Issuer or dispose of some or all of the securities" as circumstances evolve.

**Investor's Background**

Grand Fortune Capital (HK) Company Limited is a Hong Kong investment holding company that controls Grand Fortune Capital LLC and oversees ExcelFin SPAC LLC. ExcelFin served as the sponsor of ExcelFin Acquisition Corp., which combined with Baird Medical Investment Holdings Ltd. The group focuses on event-driven opportunities such as SPAC sponsorships and structured investments around corporate transactions.

Original SEC Filing: Baird Medical Investment Holdings Ltd \[ BDMD \] - SCHEDULE 13D - Jul. 31, 2026

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [BDMD.US](https://longbridge.com/en/quote/BDMD.US.md)
- [06678.HK](https://longbridge.com/en/quote/06678.HK.md)

## Related News & Research

- [Earth Science Tech (ETST) Taps into New Verticals with Zoolzy Acquisition](https://longbridge.com/en/news/297674876.md)
- [TML Tender Offer - Publication of the Offer Document](https://longbridge.com/en/news/298070476.md)
- [Lakeshore Acquisition III extends SPAC combination deadline to Oct. 1 after $67,500 extension payment](https://longbridge.com/en/news/297766395.md)
- [Inflection Point Acquisition V Lifts Sponsor Share Lock-Ups](https://longbridge.com/en/news/297571081.md)
- [Wintergreen Acquisition Issues $184,635 No-Interest Convertible Note to Macro Dream for Extension](https://longbridge.com/en/news/297958106.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**